rs17078894
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000843.4(GRM6):c.727G>T(p.Val243Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0037 in 1,612,786 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0038 ( 40 hom. )
Consequence
GRM6
NM_000843.4 missense
NM_000843.4 missense
Scores
14
4
Clinical Significance
Conservation
PhyloP100: 0.841
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.015617073).
BP6
Variant 5-178991554-C-A is Benign according to our data. Variant chr5-178991554-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 99657.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-178991554-C-A is described in Lovd as [Likely_benign]. Variant chr5-178991554-C-A is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00317 (482/152070) while in subpopulation SAS AF= 0.0145 (70/4814). AF 95% confidence interval is 0.0118. There are 7 homozygotes in gnomad4. There are 248 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRM6 | NM_000843.4 | c.727G>T | p.Val243Phe | missense_variant | 4/11 | ENST00000517717.3 | NP_000834.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRM6 | ENST00000517717.3 | c.727G>T | p.Val243Phe | missense_variant | 4/11 | 5 | NM_000843.4 | ENSP00000430767 | P1 | |
GRM6 | ENST00000231188.9 | c.727G>T | p.Val243Phe | missense_variant | 3/10 | 2 | ENSP00000231188 | P1 | ||
GRM6 | ENST00000650031.1 | c.727G>T | p.Val243Phe | missense_variant | 5/12 | ENSP00000497110 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00319 AC: 485AN: 151954Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
485
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00502 AC: 1261AN: 251300Hom.: 7 AF XY: 0.00568 AC XY: 772AN XY: 135838
GnomAD3 exomes
AF:
AC:
1261
AN:
251300
Hom.:
AF XY:
AC XY:
772
AN XY:
135838
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00376 AC: 5492AN: 1460716Hom.: 40 Cov.: 33 AF XY: 0.00420 AC XY: 3050AN XY: 726710
GnomAD4 exome
AF:
AC:
5492
AN:
1460716
Hom.:
Cov.:
33
AF XY:
AC XY:
3050
AN XY:
726710
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00317 AC: 482AN: 152070Hom.: 7 Cov.: 32 AF XY: 0.00333 AC XY: 248AN XY: 74368
GnomAD4 genome
AF:
AC:
482
AN:
152070
Hom.:
Cov.:
32
AF XY:
AC XY:
248
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
10
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
24
ExAC
AF:
AC:
562
Asia WGS
AF:
AC:
19
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | GRM6: BS1, BS2 - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 26, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 25, 2016 | - - |
Congenital stationary night blindness 1B Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 27, 2022 | - - |
GRM6-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;.
Polyphen
D;D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at